Clinical Trials Directory

Trials / Terminated

TerminatedNCT00737295

Ultrasound for Diagnosis of Biliary Dyskinesia

Study to Investigate the Role of Ultrasound for Diagnosis of Biliary Dyskinesia

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Texas Tech University Health Sciences Center · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, non-randomized study of 50 people with suspected biliary dyskinesia. The purpose of this study is to investigate if it is possible to use ultrasound to make a diagnosis of a condition called biliary dyskinesia. The investigators null hypothesis is that there will be no statistical difference between the proposed experimental test (Ultrasound) and the HIDA scan (a nuclear medicine hepatobiliary system scan) in the diagnosis of biliary dyskinesia.

Conditions

Interventions

TypeNameDescription
PROCEDURECCK Injection and UltrasoundAll subjects, whether they participate in this study or not, will undergo the HIDA scan as this is the accepted standard of care for diagnosing biliary dyskinesia. If a given subject agrees to participate in this study, he/she will be asked to undergo the following study procedures: If a pregnancy test has not already been done, a urine pregnancy test will be done for women of childbearing potential. An intravenous line (IV) will be inserted (if not already in place), and a standard dose of CCK (Kinevac®- 0.02 µg/kg) will then be injected according to the package insert. Ultrasound will be used to measure dimensions of the gallbladder (length, width and height) every minute for 35 minutes following injection of the CCK. This will be done by applying ultrasound jelly to the upper part of the abdomen and ultrasound probe will be used to obtain optimal images for three dimensional analysis of the subject's gallbladder.

Timeline

Start date
2008-05-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2008-08-18
Last updated
2010-11-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00737295. Inclusion in this directory is not an endorsement.